A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001
Clinical trial NCT05121831 · COMPLETED
Trial details
- NCT number
- NCT05121831
- Sponsor
- Digestome Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2022-11-06
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.